Study of Two Formulations of GSK Biologicals' Varicella Vaccine Given as a 2-dose Course in the Second Year of Life.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2018
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Chickenpox
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 23 Dec 2011 Actual patient number is 244 according to ClinicalTrials.gov.
- 23 Jun 2008 The expected completion date for this trial was 1 Apr 2008, according to ClinicalTrials.gov.
- 23 Jun 2008 Status changed from recruiting to completed, reported by ClinicalTrials.gov.